
Geovax Labs fell 99.1% from $12.52 to $0.11, behind the S&P 500's +10.0%. Its worst day was Dec 19 (−33.7%), and its low came Nov 10 at $0.11.
Nov 10, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-7.75 missed the $-6.50 estimate on $0.00 revenue.
−3.8% · S&P 500 0.0%
Geovax Labs shares fell 33.7%, while the S&P 500 rose 0.9%.
Story events cover the past 12 months · Times ET
−33.7%, the year's worst day · S&P 500 +0.9%
Geovax Labs shares fell 27.3%, while the S&P 500 rose 0.1%.
−27.3% · S&P 500 +0.1%
EPS of $1.85 beat the $-8.75 estimate on $0.00 revenue.
−4.5% · S&P 500 +0.8%
EPS of $-2.62 missed the $-1.79 estimate on $0.00 revenue.
−2.4% · S&P 500 −1.2%
Geovax Labs shares fell 23.5%, while the S&P 500 fell 0.0%.
−23.5% · S&P 500 0.0%
EPS of $-0.97 beat the $-2.15 estimate on $0.00 revenue.
−4.4% · S&P 500 +0.2%
Where it ended: a close of $0.11 on Nov 10, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $-1.08).
Nothing in the past 12 months.
All GOVX dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for GOVX and SPY from Benzinga historical bars. Not investment advice.